Schedule 13G ownership disclosure

ADAPTIMMUNE THERAPEUTICS PLC

Ordinary Shares · CUSIP: 00653A107

Event date: 2025-08-15

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • EcoR1 Capital, LLC

    Shares: 66,000,000.00 · Class: 4.2%

  • Oleg Nodelman

    Shares: 66,000,000.00 · Class: 4.2%

  • EcoR1 Capital Fund Qualified, L.P.

    Shares: 63,184,650.00 · Class: 4.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000935836-25-000544
Form type
SCHEDULE 13G/A
Filer
Adaptimmune Therapeutics PLC
CIK
CIK 1621227
Filed
Aug 19, 2025
Reporting period
Aug 15, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub